Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- Adults aged 18 or older.
- People who show signs of a possible stroke, identified by standard stroke screening tools used by emergency teams.
- People whose symptoms started within the last 24 hours.
- People who are able to give informed consent to take part.
- People who are not having a stroke but are a similar age, race, gender, and have similar health conditions (such as diabetes, high blood pressure, irregular heartbeat, or high cholesterol) — these people may be included as a comparison group.
- Friends or family members accompanying a patient may also be included as part of the comparison group.
- Note: People presenting with possible stroke symptoms who also have any of the following conditions may still be included and have samples collected, as long as symptoms began within 24 hours (confirm with trial site):
- A brain or nervous system infection (such as meningitis or encephalitis) in the past 30 days
- A head injury, stroke, or bleeding in the brain in the past 30 days
- Known cancer that has affected the brain
- An active cancer diagnosis or cancer treatment within the past 6 months, or cancer that has returned or spread
- An autoimmune condition such as lupus, rheumatoid arthritis, Crohn's disease, or ulcerative colitis
- An active infectious disease such as HIV/AIDS or hepatitis C
- Major surgery within the three months before the stroke symptoms began
Who may not be able to join:
- People whose stroke symptoms clearly started more than 24 hours before assessment.
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Timothy H Rainer, MD, The University of Hong Kong
Phone: +852 39176846
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Differentiation of stroke from non-stroke in patients with suspected stroke
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.